Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras.
C Ponce, E Ponce, A Morrison...
https://pubmed.ncbi.nlm.nih.gov/1670724Completed
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2008-03-04
250
Participants Needed
1
Research Sites
N/A
Total Duration
Mechanisms of host immune response to intracellular protozoa will be investigated in patients with naturally acquired infection employing a variety of in-vitro techniques. Both non-specific and antigen-specific humoral and cellular immune responses will be assessed. Parasites will be isolated from patients, cultivated in-vitro, and characterized. Responses to chemotherapy will be assessed parasitologically, immunologically and clinically.
CONDITIONS
Clinical Investigation of Infections Due to Leishmanial Parasites
You may qualify if you...
Must be between the ages of 1 and 65 years.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 1 location
1
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States, 20892
Status Unknown
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
C Ponce, E Ponce, A Morrison...
https://pubmed.ncbi.nlm.nih.gov/1670724O Velasco, S J Savarino, B C Walton...
https://pubmed.ncbi.nlm.nih.gov/2802018R Badaro, E Falcoff, F S Badaro...
https://pubmed.ncbi.nlm.nih.gov/2104665